PCSK9 inhibition for patients with and without prior coronary revascularization: Potential additional benefit of a novel therapeutic agent
Journal article published in 2018 by
Eliano P. Navarese 
,
Paolo Raggi
,
Paolo Raggi
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 